Hyperbaric Oxygen Therapy for Intracranial Abscess
HBOT is an FDA-approved adjunct for intracranial abscess, used with neurosurgical drainage and antibiotics in selected cases. Here is what the evidence shows.
An intracranial abscess is a pocket of pus that forms inside the skull, either within brain tissue (a brain abscess) or in the spaces around the brain (subdural empyema or epidural empyema). Standard care is neurosurgical drainage of the pus together with several weeks of intravenous antibiotics. Hyperbaric oxygen therapy sits on the FDA and UHMS list of approved HBOT indications for this condition, used as an adjunct in selected cases where drainage and antibiotics alone have not controlled the infection.
The word adjunct is the whole story here. HBOT does not drain an abscess, and it is not a substitute for antibiotics or surgery. It is added to standard neurosurgical care for a specific group of patients, nearly all of whom are already admitted to a hospital. It also helps to know up front that the clinical evidence behind this indication comes mostly from case series and one comparative cohort study, not from large randomized trials.
What an Intracranial Abscess Is
Bacteria reach the brain a few different ways. They can spread from a nearby infection in the middle ear, the mastoid, the sinuses, or the teeth. They can travel through the bloodstream from an infection elsewhere in the body, including heart valves and lungs. They can also be introduced directly by a penetrating head injury or during neurosurgery.
Once established, the infection moves through an early inflammatory stage and then walls itself off behind a capsule. Symptoms vary with the size and location of the abscess and often build over days. Headache is the most common complaint. Fever, new weakness or speech trouble, seizures, and a declining level of consciousness can all appear, and rising pressure inside the skull is a real danger. This is a neurosurgical emergency that is diagnosed and managed in the hospital, usually with CT or MRI imaging and cultures taken at the time of drainage.
Many brain abscesses involve anaerobic or mixed bacteria. That detail matters, because it is part of why an oxygen-based therapy has a plausible role here at all.
How HBOT Is Used Alongside Surgery and Antibiotics
HBOT is adjunctive, which means it accompanies the work surgeons and infectious disease physicians are already doing. After the abscess is drained, the high oxygen concentration delivered in the chamber works against the infection in a few ways.
Anaerobic bacteria do not tolerate high oxygen tension well. Raising the oxygen level in and around the infected tissue makes the environment hostile to them. HBOT also restores the oxygen-dependent killing power of white blood cells, which struggle to function in tissue that has become oxygen-starved. There is a third effect specific to the brain. The rise in oxygen lets blood vessels constrict slightly, which can lower swelling and pressure around the abscess while the tissue still gets the oxygen it needs.
When an abscess is connected to infected skull bone, the same oxygen effects that support treatment of chronic bone infection come into play. The underlying mechanism is the one that HBOT relies on across its infection and wound indications, explained in plain terms in what hyperbaric oxygen therapy is.
Published case series describe treatment at roughly 2.0 to 2.5 ATA for sessions of about 60 to 90 minutes. One of the larger series reported an average near 14 sessions in patients who did not also have bone involvement. Those figures describe what has been reported, not a prescription. Protocols vary, and the care team sets the schedule based on the patient and the response.
What the Research Shows
The strongest comparison available comes from Bartek and colleagues (2016), who studied 40 adults with spontaneous brain abscess treated surgically over an 11-year period. Twenty patients received standard care with surgery and antibiotics, and twenty also received adjuvant HBOT. In the HBOT group, 2 patients (10%) needed a repeat operation, compared with 9 patients (45%) who had standard care alone. A good recovery, scored as the top result on the Glasgow Outcome Scale, was reached by 16 of the HBOT patients (80%) versus 9 (45%) in the comparison group. The abscess resolved in every patient, and the authors reported that HBOT was well tolerated. PMID: 27113742.
That result is encouraging, and it is also worth reading with care. It was a single retrospective cohort, not a randomized trial. The numbers were small, and patients were not randomly assigned to the two groups. No randomized controlled trials of HBOT for intracranial abscess have been published, and the rest of the evidence is case reports and small series. So while this is a recognized indication, the proof behind it is observational, and honest sources describe the data as limited.
Who It Is Considered For
HBOT is not used for every brain abscess. Most patients do well with drainage and antibiotics, and adding HBOT is reserved for harder situations. The UHMS describes adjunct HBOT as something to consider when one or more of these apply:
- The patient has multiple abscesses.
- The abscess sits in a deep or dominant area of the brain.
- The patient is immunocompromised.
- Surgery is contraindicated, or the patient is a poor surgical candidate.
- The infection deteriorates or fails to respond despite standard surgical and antibiotic treatment.
This is inpatient, specialist-directed care. The decision usually brings together a neurosurgeon, an infectious disease physician, and a hyperbaric medicine physician, and it is made for someone who is already hospitalized. It is not an outpatient therapy, and it is not something to pursue for an infection that has already cleared or for vague neurological symptoms. Brain abscess shares this adjunct-to-surgery pattern with other infection indications such as necrotizing soft tissue infections, where HBOT also supports surgery rather than replacing it.
Coverage is handled by the hospital. Medicare’s national coverage policy for HBOT spells out the specific conditions it will pay for, payer rules are detailed, and they change over time, so HBOT for an intracranial abscess may be covered for qualifying patients only after the documentation is reviewed. The billing team confirms this before treatment. To see how this condition fits with the rest, browse the full list of conditions treated with HBOT.
Frequently Asked Questions
Is HBOT FDA-approved for an intracranial abscess?
Yes. Intracranial abscess is one of the indications the FDA and the UHMS recognize for hyperbaric oxygen therapy. It is approved as an adjunct, meaning it is used together with neurosurgical drainage and antibiotics, not in place of them.
Does HBOT replace surgery for a brain abscess?
No. Draining the abscess and treating it with antibiotics is the foundation of care. HBOT is added for selected patients, such as those with multiple or deep abscesses or those who are not responding to standard treatment.
How strong is the evidence?
It is limited. The most useful study is a single comparative cohort of 40 patients (Bartek and colleagues, 2016), supported by case reports and small series. No randomized controlled trials have been published, so the evidence is best described as observational.
How many HBOT sessions does an intracranial abscess need?
There is no fixed number. Published case series report treatment around 2.0 to 2.5 ATA with an average near 14 sessions in patients without bone involvement, but protocols vary. The care team sets the schedule. Ask the treating physicians what they recommend for the specific case.
References
Bartek, J. Jr. et al. (2016). Hyperbaric oxygen therapy in spontaneous brain abscess patients: a population-based comparative cohort study. Acta Neurochirurgica. PMID: 27113742. https://pubmed.ncbi.nlm.nih.gov/27113742/
Hyperbaric Oxygen Therapy for Intracranial Abscess. StatPearls, NCBI Bookshelf. PMID: 29630279. https://www.ncbi.nlm.nih.gov/books/NBK493227/
Undersea and Hyperbaric Medical Society. Hyperbaric Oxygen Therapy Indications, 15th Edition: Intracranial Abscess. https://www.uhms.org/8-intracranial-abscess.html
Medical Disclaimer: This page is for informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before pursuing any medical treatment.